Press release
Lawsuit filed for Investors who lost money with shares of Viatris Inc. (NASDAQ: VTRS)
A lawsuit was filed on behalf of investors in Viatris Inc. (NASDAQ: VTRS) shares over alleged securities laws violations.
Investors who purchased shares of Viatris Inc. (NASDAQ: VTRS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 03, 2025. NASDAQ: VTRS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Canonsburg, PA based Viatris Inc. operates as a healthcare company worldwide.
On February 27, 2025, Viatris Inc. announced its financial results for the fourth quarter and full fiscal year 2024 and provided disappointing fiscal 2025 guidance. The Company attributed below-expectation guidance on "the expected financial impact from Indore facility warning letter and import alert." Following this news, the price of Viatris' common stock declined dramatically.
Shares of Viatris Inc. (NASDAQ: VTRS) declined from $13.55 per share on November 25, 2024 to as loiw as $8.77 per share on February 27, 2025.
According to the complaint the plaintiff alleges on behalf of purchasers of Viatris Inc. (NASDAQ: VTRS) common shares between August 8, 2024 and February 26, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 8, 2024 and February 26, 2025, the
Those who purchased shares of Viatris Inc. (NASDAQ: VTRS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Viatris Inc. (NASDAQ: VTRS) here
News-ID: 3972384 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of Primo Brands Corporati …
An investor, who purchased shares of Primo Brands Corporation (NYSE: PRMB), filed a lawsuit over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Primo Water (formerly NYSE: PRMW) between June 17, 2024 through November 8, 2024, and/or purchased a significant amount of shares Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 through November 6,…
Lawsuit Alert: Investors who lost a substantial amount with Telix Pharmaceutical …
An investor, who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Telix Pharmaceuticals Limited in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2026. NASDAQ: TLX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ …
An investigation was announced for long-term investors in shares of Savara Inc. (NASDAQ: SVRA) concerning potential breaches of fiduciary duties by certain directors of Savara Inc.
Investors who are current long term investors in Savara Inc. (NASDAQ: SVRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SVRA stocks…
Lawsuit filed for Investors who lost money with shares of Inspire Medical System …
An investor, who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP), filed a lawsuit over alleged violations of Federal Securities Laws by Inspire Medical Systems, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP) have certain options and for certain investors are short and strict deadlines running. Deadline: January 5, 2026. NYSE: INSP investors should contact the Shareholders…
More Releases for Viatris
United States General Anesthesia Drugs Market Insights & Growth Opportunities | …
Global General Anesthesia Drugs Market is estimated to reach at a CAGR of 3.84% during the forecast period (2024-2031).
United States General Anesthesia Drugs Market size in 2024: USD 2.8 B and projected to reach USD 4.5 B by 2032 with a CAGR of 7.0% (2024-2032)
Japan General Anesthesia Drugs Market size in 2024: USD 0.5 B and projected to reach USD 1.2 B by 2032 with a CAGR of 5.6%…
Abacavir Market is Booming Worldwide with GlaxoSmithKline, Viatris, Cipla
The latest study released on the Global Abacavir Market by HTF MI evaluates market size, trend, and forecast to 2031. The Abacavir market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This Report…
Naloxone Market Growth in Future Scope 2024-2031 | Akorn, Inc, Hikma Pharmaceuti …
The Latest research report on the Naloxone Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Naloxone Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics, cost structures,…
Influenza Vaccines Industry May See a Big Move | BIKEN, Viatris, Sinovac Biotech
Data Insights Market published a new research publication on "Influenza Vaccines Industry Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Influenza Vaccines Industry was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Motion Sickness Drugs Market Is Booming Worldwide | Hylands,Perrigo, Viatris
The "Motion Sickness Drugs Market" intelligence report, just published by USD Analytics Market, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Motion Sickness Drugs Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major…
Pulmonary Arterial Hypertension Market Is Booming Worldwide with Bayer, Sandoz, …
Pulmonary Arterial Hypertension Market latest research report added by USD Analytics. The Pulmonary Arterial Hypertension Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in…
